Publication
Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.
Paolo Tarantino, Tianyu Li, Laia Paré Brunet, Esther Sanfeliu, Beyza Koca, Ruby Guo, Marta Ollé-Monge, Olga Martínez-Sáez, Olivia Cunningham, Melissa E Hughes, Ashka Patel, Tari A King, Elizabeth A Mittendorf, Nancy U Lin, Fara Brasó-Maristany, Guillermo Villacampa, Patricia Villagrasa, Nabihah Tayob, Aleix Prat, Sara M Tolaney
- Source
- PubMed
- Retrieved
- Oct 2, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20261002-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: One-third of patients with triple-negative breast cancer (TNBC) are diagnosed with stage I tumors. Biomarkers to stratify prognosis in this setting remain a major unmet need. METHODS: Tissue samples and clinicopathologic data were retrieved from consecutive patients with stage I TNBC…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Breast Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available